Clinical trial
Reduced-Intensity Conditioning Followed By Donor Peripheral Blood Stem Cell…
NCT00054353 · Fred Hutchinson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00054353 |
|---|---|
| Title | Reduced-Intensity Conditioning Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma |
| Official title | Reduced-Intensity Allogeneic HSC Transplantation From HLA-Matched Related and Unrelated Donors for Patients With Multiple Myeloma - A Multi-Center Trial |
| Lead sponsor | Fred Hutchinson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Refractory Multiple Myeloma |
| Intervention type | Drug, Other, Procedure, Radiation |
| Interventions | fludarabine phosphate, melphalan, total-body irradiation, mycophenolate mofetil, cyclosporine, nonmyeloablative allogeneic hematopoietic stem cell transplantation, peripheral blood stem cell transplantation, laboratory biomarker analysis |
| Enrollment | 16 |
| Start date | Oct 1, 2002 |
| Primary completion | Oct 1, 2009 |
| Completion | Oct 14, 2012 |
| First posted | Feb 6, 2003 |
| Last update posted | Oct 16, 2017 |
| Countries | Italy, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: